Previous 10 | Next 10 |
The Company’s Virtual Presentation is Scheduled at 1:00 pm – 1:25 pm EST on April 20th, 2021 NEW YORK, NY, April 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a...
These E-Commerce Records Were Achieved on the Date: Monday – April 5, 2021 NEW YORK, April 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversif...
The Company is Focused on the International Expansion of Its Flagship Brand Tauri-Gum™ NEW YORK, NY, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue gener...
The Company is a Verified Federal Government Vendor (CAGE CODE # 8QXV4) NEW YORK, NY, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified li...
NEW YORK, NY, March 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Suppleme...
Commercial Launch of Tauri-Pet™ Product Line is Anticipated: April 20, 2021 NEW YORK, NY, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating...
Tauriga Sciences (TAUG) announces that the company has filed an International Patent Application under the Patent Cooperation Treaty relating to its proposed Pharmaceutical Cannabinoid Chewing Gum Delivery System being developed to treat: Nausea Derived from Active Chemotherapy Trea...
NEW YORK, NY, March 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Suppleme...
To Enhance Its Existing Intellectual Property Portfolio, the Company Filed an Additional U.S. Provisional Patent Application Directed to: Alternative Pharmaceutical Cannabinoid Delivery Systems NEW YORK, NY, March 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences...
The Company is Focused on Both Increasing Tauri-Gum™ Brand Awareness and E-Commerce Revenue NEW YORK, NY, March 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue...
News, Short Squeeze, Breakout and More Instantly...
Tauriga Sciences Inc (TAUG) is expected to report for Q3 2023
NEW YORK, NY - ( NewMediaWire ) - May 13, 2022 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York-based diversified Life Sciences and Pharmaceutical Development Company, today announced that the online shopping research platform, FindT...
New York, NY, May 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences and Pharmaceutical Development Company, today announced that its Chief Ex...